These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 31848930)
1. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4. Ye C; Zhang X; Chen X; Cao Q; Zhang X; Zhou Y; Li W; Hong L; Xie H; Liu X; Cao H; Wang YJ; Kang B Cell Oncol (Dordr); 2020 Apr; 43(2):279-295. PubMed ID: 31848930 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma. Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731 [TBL] [Abstract][Full Text] [Related]
3. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression. Chang TS; Wu YC; Chi CC; Su WC; Chang PJ; Lee KF; Tung TH; Wang J; Liu JJ; Tung SY; Kuo LM; Ho HN; Ling TY; Huang YH Clin Cancer Res; 2015 Jan; 21(1):201-10. PubMed ID: 25564572 [TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
5. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
6. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis. Chen Z; Chen J; Huang X; Wu Y; Huang K; Xu W; Xie L; Zhang X; Liu H J Comput Biol; 2019 May; 26(5):485-494. PubMed ID: 30864827 [No Abstract] [Full Text] [Related]
7. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776 [TBL] [Abstract][Full Text] [Related]
8. Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma. Wang G; Zhou H; Gu Z; Gao Q; Shen G Oncol Rep; 2018 Aug; 40(2):979-987. PubMed ID: 29901157 [TBL] [Abstract][Full Text] [Related]
9. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis]. Li Y; Wu D; Wei C; Yang X; Zhou S Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection. Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma. Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467 [TBL] [Abstract][Full Text] [Related]
12. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069 [TBL] [Abstract][Full Text] [Related]
13. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma. Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004 [TBL] [Abstract][Full Text] [Related]
14. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4. Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816 [TBL] [Abstract][Full Text] [Related]
15. Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma. Yang A; Liu J; Li M; Zhang H; Zhang X; Wu L Diagn Pathol; 2024 Aug; 19(1):105. PubMed ID: 39095799 [TBL] [Abstract][Full Text] [Related]
16. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Li Z; Xu J; Cui H; Song J; Chen J; Wei J Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377 [TBL] [Abstract][Full Text] [Related]
20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]